Affinity DataKi: 4nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 7.80nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 15.3nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 37nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 39nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 42nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 52nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 60nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 160nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 510nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 650nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 670nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 810nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 870nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 1.70E+3nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair
Affinity DataKi: 5.60E+3nMAssay Description:Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]-PTA-OH binding affinity to human plateletsMore data for this Ligand-Target Pair